Blog

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today

Vodafone Qatar and Inseego (Nasdaq: INSG) are bringing lightning-fast internet access to home and business customers with the launch of the new 5G indoor router FX2000. Combining 5G performance

Pfizer Inc. (NYSE: PFE) and Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Arena, a clinical

Demand for improved customer experience is the top driver of digital transformation in Europe’s insurance industry, but with growing digitalization, insurers report increasing security

Northern Trust (Nasdaq: NTRS) has further enhanced its suite of environmental, social and governance (ESG) investment analytics to deliver new climate risk reporting for global institutional

Wells Fargo & Company (NYSE: WFC) and HSBC Bank plc today announced an agreement to use a blockchain-based solution for the netting and settlement of matched foreign exchange (FX) transactions

EML Payments (ASX: EML) (S&P/ASX 200), is the biggest name in retail gifting card solutions worldwide, powering some of the largest retailers in the world and supporting local communities globally

Eurofins Technologies (Paris:ERF), a supplier of test kits and systems for laboratory analyses, announces the launch of its new RapidScan ST5-W lateral flow reader, specifically designed for field

Regulatory News:

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Vifor is in discussions with CSL about a possible transaction. No decisions have been made yet and there is no time frame for this

Regulatory News:

GeNeuro (Euronext Paris: CH0308403085 - GNRO) (Paris:GNRO), a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases, with final

Gensource Potash Corporation (“Gensource” or the “Company”) (TSXV: GSP, AIM: GSP) today announced that it has filed and obtained a final receipt (the “Receipt”) for a final short form base shelf

Elliptic Labs (EuroNext Growth: ELABS.OL), a global AI software company and the world leader in AI Virtual Smart Sensors^TM, has signed a license agreement with a new Asia-based smartphone

Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced updated preliminary proof-of-concept clinical data from the Phase 1/2 PRECIZN-1 study of SAR445136, a zinc

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced

Regulatory News:

MaaT Pharma (EURONEXT: MAAT - the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving

R.R. Donnelley & Sons Company (NYSE: RRD) (“RRD” or the “Company”) announced today that its Board of Directors (the “Board”) unanimously determined that an unsolicited proposal from Chatham Asset

Essex Property Trust, Inc. (NYSE:ESS) announced today that its Board of Directors has declared a regular quarterly cash dividend of $2.09 per common share, payable January 14, 2022 to shareholders

SunMirror AG ("SunMirror", "the Company"; Vienna Stock Exchange: ROR1; Frankfurt Stock Exchange: ROR; ISIN CH0396131929) is pleased to announce experienced senior executives to join the SunMirror's

Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, presented an update from its Phase II SUMMIT trial at the ongoing 2021 San Antonio Breast Cancer Symposium (SABCS) Annual

Vifor Pharma today announced that the first patient has been enrolled in a double-blind, randomized phase-IIa clinical trial evaluating the safety, efficacy and tolerability of vamifeport in adult

Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company’s common stock to $0.40 for the first-quarter 2022 dividend

HydraFacial, flagship brand of The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health, is finishing its 2021 #GLOWvolution Tour with an

Exelon Corp. (Nasdaq: EXC) hosted U.S. Secretary of Energy Jennifer M. Granholm on a tour of Exelon’s Braidwood Generating Station in Will County to highlight the economic and environmental

Okta, Inc. (NASDAQ:OKTA), the leading independent provider of identity, today announced it has joined the OpenID Foundation as a sustaining member. The new board position for Okta follows